{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:02:49Z","timestamp":1787781769710,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Programof the Joint Fund of Scientific Research for the Public Hospitalsof Inner Mongolia Academy of Medical Sciences","award":["2024GLLH1331"],"award-info":[{"award-number":["2024GLLH1331"]}]},{"name":"Inner Mongolia Natural Science Foundation Project","award":["2020MS08177"],"award-info":[{"award-number":["2020MS08177"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04453-9","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:31:53Z","timestamp":1752834713000},"page":"709-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Abnormal coagulation indicators associated with \u03b2-lactamantibacterial drug: a pharmacovigilance study based on the FAERS database"],"prefix":"10.1007","volume":"399","author":[{"given":"Xuemei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peitao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"1","key":"4453_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000238469","volume":"33","author":"G Agnelli","year":"1987","unstructured":"Agnelli G, Guerciolini R, Grasselli S et al (1987) Effects of the monobactam antibiotic aztreonam on platelet function and blood coagulation. Chemotherapy 33(1):9\u201314. https:\/\/doi.org\/10.1159\/000238469","journal-title":"Chemotherapy"},{"issue":"9","key":"4453_CR2","doi-asserted-by":"publisher","first-page":"e0291658","DOI":"10.1371\/journal.pone.0291658","volume":"18","author":"H Bai","year":"2023","unstructured":"Bai H, Li H, Nie X et al (2023) Development and validation of a nomogram for predicting cefoperazone\/sulbactam-induced hypoprothrombinaemia in hospitalized adult patients. PLoS One 18(9):e0291658. https:\/\/doi.org\/10.1371\/journal.pone.0291658","journal-title":"PLoS One"},{"issue":"Suppl2","key":"4453_CR3","doi-asserted-by":"publisher","first-page":"S380","DOI":"10.1093\/clinids\/5.Supplement_2.S380","volume":"5","author":"NV Bang","year":"1983","unstructured":"Bang NV, Kammer RB (1983) Hematologic complications associated with betalactam antibacterial drugs. Rev Infect Dis 5(Suppl2):S380\u2013S390","journal-title":"Rev Infect Dis"},{"issue":"4","key":"4453_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4274\/tjh.2018.0127","volume":"35","author":"A Benli","year":"2018","unstructured":"Benli A, \u015eim\u015fek-Yavuz S, Ba\u015faran S et al (2018) Hematologic adverse effects of prolonged piperacillin-tazobactam use in adults. Turk J Haematol 35(4):290\u2013295. https:\/\/doi.org\/10.4274\/tjh.2018.0127","journal-title":"Turk J Haematol"},{"issue":"1","key":"4453_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s40800-016-0025-9","volume":"3","author":"Z Cai","year":"2016","unstructured":"Cai Z, Yang W, He Y et al (2016) Cefoperazone\/sulbactam-induced abdominal wall hematoma and upper gastrointestinal bleeding: a case report and review of the literature. Drug Saf Case Rep 3(1):2. https:\/\/doi.org\/10.1007\/s40800-016-0025-9","journal-title":"Drug Saf Case Rep"},{"issue":"9 Suppl","key":"4453_CR6","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1097\/00006454-198909001-00007","volume":"8","author":"SA Chartrand","year":"1989","unstructured":"Chartrand SA (1989) Safety and toxicity profile of aztreonam. Pediatr Infect Dis J 8(9 Suppl):S120\u2013S123. https:\/\/doi.org\/10.1097\/00006454-198909001-00007","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"4453_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s40264-017-0578-2","volume":"40","author":"S Deshayes","year":"2017","unstructured":"Deshayes S, Coquerel A, Verdon R (2017) Neurological adverse effects attributable to \u03b2-Lactam antibacterial drugs: a literature review. Drug Saf 40(12):1171\u20131198. https:\/\/doi.org\/10.1007\/s40264-017-0578-2","journal-title":"Drug Saf"},{"issue":"9","key":"4453_CR8","first-page":"67","volume":"21","author":"W Duan","year":"2023","unstructured":"Duan W, Chen M, Song Q et al (2023) Meta-analysis of risk factors for coagulation dysfunction induced by cefoperazone sodium and sulbactam sodium. Chin J Clin Drug Ther 21(9):67\u201374","journal-title":"Chin J Clin Drug Ther"},{"issue":"5","key":"4453_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/00185787241238310","volume":"59","author":"AI Ebid","year":"2024","unstructured":"Ebid AI, Abdeen HA, Muhammed Maher R et al (2024) Cefoperazone-sulbactam-induced coagulopathy in critically ill Egyptian patients: role of vitamin K prophylactic doses. Hosp Pharm 59(5):575\u2013583. https:\/\/doi.org\/10.1177\/00185787241238310","journal-title":"Hosp Pharm"},{"key":"4453_CR10","doi-asserted-by":"publisher","unstructured":"El-Gamal MI, Brahim I, Hisham N et al (2017) Recent updates of carbapenem antibacterial drugs. Eur J Med Chem 131:185\u2013195. https:\/\/doi.org\/10.1016\/j.ejmech.2017.03.022","DOI":"10.1016\/j.ejmech.2017.03.022"},{"issue":"3","key":"4453_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5005\/jp-journals-10071-24417","volume":"27","author":"KK Gudivada","year":"2023","unstructured":"Gudivada KK, Krishna B, Sampath S (2023) Cefoperazone-induced coagulopathy in critically ill patients admitted to intensive care unit. Indian J Crit Care Med 27(3):183\u2013189. https:\/\/doi.org\/10.5005\/jp-journals-10071-24417","journal-title":"Indian J Crit Care Med"},{"issue":"S02","key":"4453_CR12","first-page":"102","volume":"37","author":"DP Hou","year":"2021","unstructured":"Hou DP, Wang FE, Zhu J (2021) Analysis of 300 cases of coagulation dysfunction induced by cefoperazone-sulbactam. Modern Med Health 37(S02):102\u2013104","journal-title":"Modern Med Health"},{"issue":"04","key":"4453_CR13","first-page":"708","volume":"23","author":"JN Hu","year":"2020","unstructured":"Hu JN, Zhang JG, Zhu GH et al (2020) One case of severe coagulation dysfunction induced by intravenous cefotaxime. Chin Pharm 23(04):708\u2013709","journal-title":"Chin Pharm"},{"issue":"3","key":"4453_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/pds.5555","volume":"32","author":"E Hung","year":"2023","unstructured":"Hung E, Hauben M, Essex H et al (2023) More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching. Pharmacoepidemiol Drug Saf 32(3):387\u2013391. https:\/\/doi.org\/10.1002\/pds.5555","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"4453_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMra1208626","volume":"370","author":"BJ Hunt","year":"2014","unstructured":"Hunt BJ (2014) Bleeding and coagulopathies in critical care. N Engl J Med 370(9):847\u2013859. https:\/\/doi.org\/10.1056\/NEJMra1208626","journal-title":"N Engl J Med"},{"issue":"12","key":"4453_CR16","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1016\/j.jtha.2023.05.028","volume":"21","author":"T Iba","year":"2023","unstructured":"Iba T, Helms J, Neal MD et al (2023) Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation. J Thromb Haemost 21(12):3360\u20133370. https:\/\/doi.org\/10.1016\/j.jtha.2023.05.028","journal-title":"J Thromb Haemost"},{"key":"4453_CR17","doi-asserted-by":"publisher","first-page":"1524159","DOI":"10.3389\/fphar.2025.1524159","volume":"16","author":"P Jia","year":"2025","unstructured":"Jia P, Zhou Y, Gao Y et al (2025) Real-world pharmacovigilance investigation of imipenem\/cilastatin: signal detection using the FDA Adverse Event Reporting System (FAERS) database. Front Pharmacol 16:1524159. https:\/\/doi.org\/10.3389\/fphar.2025.1524159","journal-title":"Front Pharmacol"},{"key":"4453_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jad.2023.11.025","volume":"346","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Zhou L, Shen Y, et al (2024) Safety assessment of brexpiprazole: real-world adverse event analysis from the FAERS database. J Affect Disord 346:223\u2013229. https:\/\/doi.org\/10.1016\/j.jad.2023.11.025.","journal-title":"J Affect Disord"},{"key":"4453_CR19","doi-asserted-by":"publisher","unstructured":"Jin X, Lu X, Li Y (2024) Characteristics and risk factors of coagulation dysfunction induced by cefoperazone\/sulbactam in neurosurgical patients. Med J Chin People's Armed Police Force 35(6):511\u2013515.  https:\/\/doi.org\/10.14010\/j.cnki.wjyx.2024.06.008","DOI":"10.14010\/j.cnki.wjyx.2024.06.008"},{"issue":"3","key":"4453_CR20","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/S2666-5247(22)00355-X","volume":"4","author":"BJ Langford","year":"2023","unstructured":"Langford BJ, So M, Simeonova M et al (2023) Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. Lancet. Microbe 4(3):e179\u2013e191. https:\/\/doi.org\/10.1016\/S2666-5247(22)00355-X","journal-title":"Microbe"},{"issue":"3","key":"4453_CR21","first-page":"180","volume":"3","author":"HY Lin","year":"1987","unstructured":"Lin HY (1987) Bleeding and coagulation disorders induced by antibacterial drugs. J Clin Med 3(3):180\u2013181","journal-title":"J Clin Med"},{"issue":"6","key":"4453_CR22","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1007\/s11096-024-01796-w","volume":"46","author":"J Liu","year":"2024","unstructured":"Liu J, Xiao J, Wu H et al (2024) A retrospective cohort study of coagulation function in patients with liver cirrhosis receiving cefoperazone\/sulbactam with and without vitamin K1 supplementation. Int J Clin Pharm 46(6):1492\u20131499. https:\/\/doi.org\/10.1007\/s11096-024-01796-w","journal-title":"Int J Clin Pharm"},{"key":"4453_CR23","doi-asserted-by":"publisher","first-page":"1486422","DOI":"10.3389\/fphar.2024.1486422","volume":"15","author":"Y Lu","year":"2024","unstructured":"Lu Y, Xu Q, Zhu S (2024) Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system. Front Pharmacol 15:1486422. https:\/\/doi.org\/10.3389\/fphar.2024.1486422","journal-title":"Front Pharmacol"},{"key":"4453_CR24","doi-asserted-by":"publisher","unstructured":"Lv Y, Wen J, Wei X (2019) Relationship between adverse reaction mechanisms of cephalosporins and their chemical structures. Chin J Hosp Pharm 35(11):1050\u20131054.  https:\/\/doi.org\/10.13286\/j.cnki.chinhosppharmacyj.2015.11.22","DOI":"10.13286\/j.cnki.chinhosppharmacyj.2015.11.22"},{"issue":"6","key":"4453_CR25","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/infdis\/158.6.1405","volume":"158","author":"RV McCloskey","year":"1988","unstructured":"McCloskey RV (1988) Spontaneous reports of bleeding: comparison of N-methylthiotetrazole side chain (MTT) and non-MTT cephalosporins. J Infect Dis 158(6):1405. https:\/\/doi.org\/10.1093\/infdis\/158.6.1405","journal-title":"J Infect Dis"},{"issue":"03","key":"4453_CR26","first-page":"213","volume":"39","author":"R Niu","year":"2019","unstructured":"Niu R, Zhao MY, Dai J et al (2019) Mining of adverse reaction signals of carbapenems and analysis of related influencing factors. Northwest J Pharm 39(03):213\u2013218","journal-title":"Northwest J Pharm"},{"issue":"6","key":"4453_CR27","doi-asserted-by":"publisher","first-page":"bbab347","DOI":"10.1093\/bib\/bbab347","volume":"22","author":"Y Noguchi","year":"2021","unstructured":"Noguchi Y, Tachi T, Teramachi H (2021) Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief Bioinform 22(6):bbab347. https:\/\/doi.org\/10.1093\/bib\/bbab347","journal-title":"Brief Bioinform"},{"issue":"8","key":"4453_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST (2004) The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 13(8):519\u2013523. https:\/\/doi.org\/10.1002\/pds.1001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"4453_CR29","first-page":"780","volume":"29","author":"M Shao","year":"2020","unstructured":"Shao M, Xue M, Wang S (2020) Expert consensus on the diagnosis and treatment of acute hemorrhagic coagulopathy. Chin J Emerg Med 29(6):780\u2013787","journal-title":"Chin J Emerg Med"},{"key":"4453_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.4.699","author":"BG Spratt","year":"1988","unstructured":"Spratt BG et al (1988) Penicillin-binding proteins of gram-negative bacteria. Clin Infect Dis. https:\/\/doi.org\/10.1093\/clinids\/10.4.699","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4453_CR31","first-page":"151","volume":"41","author":"HY Sun","year":"2008","unstructured":"Sun HY, Chen YC, Wang YW et al (2008) A prospective study of antimicrobial-related adverse drug reactions in hospitalized patients. J Microbiol Immunol Infect 41(2):151\u2013159","journal-title":"J Microbiol Immunol Infect"},{"key":"4453_CR32","unstructured":"The Expert Committee on Rational Drug Use of the National Health Commission of China (2023)  Title of\u00a0national bacterial resistance surveillance report (summary edition). In: China antimicrobial resistance surveillance system. https:\/\/www.carss.cn\/Report\/Details?aId=978.\u00a0Accessed 18 Nov 2024"},{"issue":"12","key":"4453_CR33","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1080\/14740338.2022.2078301","volume":"21","author":"X Tian","year":"2022","unstructured":"Tian X, Zheng S, Wang J et al (2022) Cardiac disorder-related adverse events for aryl hydrocarbon receptor agonists: a safety review. Expert Opin Drug Saf 21(12):1505\u20131510. https:\/\/doi.org\/10.1080\/14740338.2022.2078301","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"4453_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/14740338.2020.1713090","volume":"19","author":"W Wang","year":"2020","unstructured":"Wang W, Liu Y, Yu C et al (2020) Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study. Expert Opin Drug Saf. 19(3):339\u2013347. https:\/\/doi.org\/10.1080\/14740338.2020.1713090","journal-title":"Expert Opin Drug Saf."},{"issue":"4","key":"4453_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.19577\/j.10074406.2022.04.008","volume":"31","author":"QS Wu","year":"2022","unstructured":"Wu QS, Deng QJ (2022) Risk factors of coagulation disorders induced by cefoperazone sulbactam. Chin J Clin Pharm 31(4):277\u2013281. https:\/\/doi.org\/10.19577\/j.10074406.2022.04.008","journal-title":"Chin J Clin Pharm"},{"issue":"12","key":"4453_CR36","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/j.clinthera.2021.10.005","volume":"43","author":"S Wu","year":"2021","unstructured":"Wu S, Wu G, Wu H (2021) A comparison of coagulation function in patients receiving aspirin and cefoperazone-sulbactam with and without vitamin K1: a retrospective, observational study. Clin Ther 43(12):e335\u2013e345. https:\/\/doi.org\/10.1016\/j.clinthera.2021.10.005","journal-title":"Clin Ther"},{"issue":"4","key":"4453_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jmii.2023.01.017","volume":"56","author":"M Zeng","year":"2023","unstructured":"Zeng M, Xia J, Zong Z et al (2023) Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect 56(4):653\u2013671. https:\/\/doi.org\/10.1016\/j.jmii.2023.01.017","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"4453_CR38","first-page":"274","volume":"30","author":"J Zeng","year":"2024","unstructured":"Zeng J, Zou M, Min M et al (2024) Characteristics and influencing factors of coagulation dysfunction caused by cefoperazone\/sulbactam. Altern Ther Health Med 30(9):274\u2013278","journal-title":"Altern Ther Health Med"},{"key":"4453_CR39","doi-asserted-by":"publisher","unstructured":"Zhou L, Li X, Zhang Q (2023) Literature case analysis of severe adverse reactions of coagulation dysfunction and thrombocytopenia caused by antimicrobial agents in the elderly. Practical Pharmacy and Clinical Remedies 26(3):241\u2013246. https:\/\/doi.org\/10.14053\/j.cnki.ppcr.202303011","DOI":"10.14053\/j.cnki.ppcr.202303011"},{"key":"4453_CR40","unstructured":"Zhu Y, Liang L, Shen J et al (2022) Analysis of clinical characteristics and related factors of coagulation dysfunction induced by cefoperazone sodium and sulbactam sodium. Chin J Pharm 57(9):741\u2013746"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04453-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:08:04Z","timestamp":1771538884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04453-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4453"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04453-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not sought for this study because The FDA Adverse Event Reporting System (FAERS) database is publicly accessible, and patient identity information is anonymized. Ethical approval and informed consent were not deemed necessary for this study because the FAERS database is publicly accessible, and all patient identity information remains strictly confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}